Kono, Masashi <br/><br/>
Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.  [electronic resource] 

 -  Internal medicine (Tokyo, Japan)  May 2019 
 - 1263-1266 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1349-7235 
<br/><br/><label>Standard No.: </label>10.2169/internalmedicine.1981-18  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Albumins--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cholangitis, Sclerosing--chemically induced<br/>Female<br/>Humans<br/>Immunotherapy--adverse effects<br/>Middle Aged<br/>Nivolumab--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Stomach Neoplasms--drug therapy<br/>Ramucirumab